Literature DB >> 22977010

Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.

Changjun Yang1, M A Hassan Talukder, Saradhadevi Varadharaj, Murugesan Velayutham, Jay L Zweier.   

Abstract

AIMS: The role of endothelial nitric oxide synthase (eNOS)/NO signalling is well documented in late ischaemic preconditioning (IPC); however, the role of eNOS and its activation in early IPC remains controversial. This study investigates the role of eNOS in early IPC and the signalling pathways and molecular interactions that regulate eNOS activation during early IPC. METHODS AND
RESULTS: Rat hearts were subjected to 30-min global ischaemia and reperfusion (I/R) with or without IPC (three cycles 5-min I and 5-min R) in the presence or absence of the NOS inhibitor l-NAME, phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 (LY), and protein kinase A (PKA) inhibitor H89 during IPC induction or prior endothelial permeablization. IPC improved post-ischaemic contractile function and reduced infarction compared with I/R with this being abrogated by l-NAME or endothelial permeablization. eNOS(Ser1176), Akt(Ser473), and PKA(Thr197) phosphorylation was increased following IPC. I/R decreased eNOS(Ser1176) phosphorylation, whereas IPC increased it. Mass spectroscopy confirmed eNOS(Ser1176) phosphorylation and quantitative Western blots showed ∼24% modification of eNOS(Ser1176) following IPC. Immunoprecipitation demonstrated eNOS, Akt, and PKA complexation. Immunohistology showed IPC-induced Akt and PKA phosphorylation in cardiomyocytes and endothelium. With eNOS activation, IPC increased NO production as measured by electron paramagnetic resonance spin trapping and fluorescence microscopy. LY or H89 not only decreased Akt(Ser473) or PKA(Thr197) phosphorylation, respectively, but also abolished IPC-induced preservation of eNOS and eNOS(Ser1176) phosphorylation as well as cardioprotection.
CONCLUSION: Thus, Akt- and PKA-mediated eNOS activation, with phosphorylation near the C-terminus, is critical for early IPC-induced cardioprotection, with eNOS-derived NO from the endothelium serving a critical role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22977010      PMCID: PMC3527763          DOI: 10.1093/cvr/cvs287

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  42 in total

Review 1.  eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Authors:  Rakesh C Kukreja; Lei Xi
Journal:  J Mol Cell Cardiol       Date:  2006-12-18       Impact factor: 5.000

Review 2.  Nitric oxide and cardiac function.

Authors:  R A Kelly; J L Balligand; T W Smith
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

3.  Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury.

Authors:  John W Elrod; James J M Greer; Nathan S Bryan; Will Langston; Jeffrey F Szot; Henock Gebregzlabher; Stefan Janssens; Martin Feelisch; David J Lefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-27       Impact factor: 8.311

Review 4.  Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation.

Authors:  Peter F Mount; Bruce E Kemp; David A Power
Journal:  J Mol Cell Cardiol       Date:  2006-07-12       Impact factor: 5.000

5.  PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.

Authors:  Arnaud Robinet; Guillaume Hoizey; Hervé Millart
Journal:  Cardiovasc Res       Date:  2005-06-01       Impact factor: 10.787

6.  Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.

Authors:  Sonia Genade; Amanda Genis; Kirsti Ytrehus; Barbara Huisamen; Amanda Lochner
Journal:  J Pineal Res       Date:  2008-08-04       Impact factor: 13.007

7.  Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme.

Authors:  Chun-An Chen; Lawrence J Druhan; Saradhadevi Varadharaj; Yeong-Renn Chen; Jay L Zweier
Journal:  J Biol Chem       Date:  2008-07-13       Impact factor: 5.157

Review 8.  Signaling pathways in ischemic preconditioning.

Authors:  James M Downey; Amanda M Davis; Michael V Cohen
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.

Authors:  Adrian T Gonon; Ulrika Widegren; Aliaksandr Bulhak; Firoozeh Salehzadeh; Jonas Persson; Per-Ove Sjöquist; John Pernow
Journal:  Cardiovasc Res       Date:  2008-01-25       Impact factor: 10.787

10.  Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4.

Authors:  Cristian Dumitrescu; Roberto Biondi; Yong Xia; Arturo J Cardounel; Lawrence J Druhan; Giuseppe Ambrosio; Jay L Zweier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

View more
  25 in total

Review 1.  Redox therapeutics in hepatic ischemia reperfusion injury.

Authors:  Rakesh P Patel; John D Lang; Alvin B Smith; Jack H Crawford
Journal:  World J Hepatol       Date:  2014-01-27

2.  Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.

Authors:  M Ahsan Siraj; Dhanwantee Mundil; Sanja Beca; Abdul Momen; Eric A Shikatani; Talat Afroze; Xuetao Sun; Ying Liu; Siavash Ghaffari; Warren Lee; Michael B Wheeler; Gordon Keller; Peter Backx; Mansoor Husain
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts.

Authors:  Feng Su; Lan Zhao; Shaoheng Zhang; Jiahong Wang; Nannan Chen; Qunlin Gong; Jinhui Tang; Hao Wang; Jianhua Yao; Qin Wang; Ming Zhong; Jian Yan
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

Review 4.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

5.  Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea.

Authors:  Rami N Khayat; Saradhadevi Varadharaj; Kyle Porter; Angela Sow; David Jarjoura; Mikhail A Gavrilin; Jay L Zweier
Journal:  Am J Hypertens       Date:  2018-02-09       Impact factor: 2.689

6.  Down-Regulation of IRF6 Protects Cortical Neurons Against Traumatic Neuronal Injury Through Activating Akt-eNOS Pathway.

Authors:  Ming-Shan Hou; Jie Cao; Bo Chen; Xiao-Bin Liu
Journal:  Cell Mol Neurobiol       Date:  2016-06-15       Impact factor: 5.046

7.  Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction.

Authors:  Saradhadevi Varadharaj; Kyle Porter; Adam Pleister; Jacob Wannemacher; Angela Sow; David Jarjoura; Jay L Zweier; Rami N Khayat
Journal:  Respir Physiol Neurobiol       Date:  2014-12-19       Impact factor: 1.931

8.  Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.

Authors:  Qiming Duan; Namrata D Madan; Jian Wu; Jennifer Kalisz; Krunal Y Doshi; Saptarsi M Haldar; Lijun Liu; Sandrine V Pierre
Journal:  J Mol Cell Cardiol       Date:  2015-01-07       Impact factor: 5.000

9.  Myocardial ischemic protection in natural mammalian hibernation.

Authors:  Lin Yan; Raymond K Kudej; Dorothy E Vatner; Stephen F Vatner
Journal:  Basic Res Cardiol       Date:  2015-01-23       Impact factor: 17.165

10.  Cardiac Slo2.1 Is Required for Volatile Anesthetic Stimulation of K+ Transport and Anesthetic Preconditioning.

Authors:  Andrew P Wojtovich; C Owen Smith; William R Urciuoli; Yves T Wang; Xiao-Ming Xia; Paul S Brookes; Keith Nehrke
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.